Apyx Medical Corporation APYX Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.
The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's finance lease, right-of-use asset, after accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apyx Medical Corporation's finance lease, right-of-use asset, after accumulated amortization?
- Apyx Medical Corporation (APYX) reported finance lease, right-of-use asset, after accumulated amortization of $22K in Q1 2026.
- How has Apyx Medical Corporation's finance lease, right-of-use asset, after accumulated amortization changed year-over-year?
- Apyx Medical Corporation's finance lease, right-of-use asset, after accumulated amortization decreased by 48.8% year-over-year, from $43K to $22K.
- What is the long-term trend for Apyx Medical Corporation's finance lease, right-of-use asset, after accumulated amortization?
- Over 5 years (2020 to 2025), Apyx Medical Corporation's finance lease, right-of-use asset, after accumulated amortization has grown at a -42.3% compound annual growth rate (CAGR), from $437K to $28K.